Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CETROTIDE
- The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders
- Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles
- Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSI
- Growth Hormone Pretreatment in Poseidon Type IV Undergoing ICSI Using Minimal Induction Protocol: A Randomized Controlled Trial
- GnRH Antagonist Pre-treatment for the Prevention of Asynchronous Follicular Growth
- GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst
- Agonist Trigger With HCG Luteal Supplementation vs HCG Trigger With Progesterone Luteal Supplementation in Antagonist Controlled HyperstimulationCycle
- Testosterone and Neurovascular Control in Humans
- AOA in Recurrent Fertilization Failure
- L-carnitine and COH in PCOS Women Undergoing IVF/ICSI Cycles
- Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction
- Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders
- Estrogen, Diabetes, and Endothelial Function
- The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy
- Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles
- Frozen Embryo Transfer With GnRH-antagonist Trial
- The Impact of Body Weight on Reproductive Outcomes in Poor Ovarian Responders in ICSI Cycles
- Poor Responders Infertile Patients -A Great Clinical Challenge
- DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore
- Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles
- Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI
- AMH and Dosing Regimens for Initial IVF Stimulation Protocols
- Androgenic Profile Following Controlled Ovarian Stimulation
- Letrozole in Stimulated IVF Cycles
- A Retrospective Study in Chinese Good Prognosis Patients Undergoing Assisted Reproductive Technology (ART) Treatment
- Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome
- Evaluation of Different Luteal Phase Support Methods in Patients With Poor Ovarian Response
- Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI
- Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response
- Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program
- DHEA Versus Placebo in Women With Poor Ovarian Response
- Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase
- Effect of Cabergoline on Endometrial Vascularity During IntraCytoplasmic Sperm Injection
- Efficacy of Pergoveris in Aged IVF Patients
- Does Dehydro Epiandrosterone (DHEA) Improve Pregnancy Rate in Women Undergoing IVF/ICSI With Expected Poor Ovarian Response?
- Implantation Enhancement by Elective Cryopreservation of All Viable Embryos
- Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women
- Human Chorionic Gonadotrophin in an Antagonist Protocol
- Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS)
- Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity
- Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression
- Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days
- Reproductive Hormonal Alterations in Obesity
- GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer
- Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)
- Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)
- An Observational Study of Cetrotide® Gonadotropin-releasing Hormone Antagonist (GnRH Antagonist) With GONAL-f® in Assisted Reproductive Technologies (ART)
- The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors
- Cetrotide Treatment Optimization
- Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids
- Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation
- Effect of Cetrorelex Acetate on Ovarian Function in Women Undergoing Chemotherapy
- GnRH Antagonist to Prepare Recipients for Embryo Transfer
- Synchronization of Follicle Wave Emergence and Ovarian Stimulation
- A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation
Clinical trials list
click for details